Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Evidence for the safe use of Lumason® (SonoVue®), an ultrasound enhancing agent (UEA), in special patient populations is critical to enable healthcare professionals to make informed decisions concerning its use in such patients. Herein, we provide insight on the safety and tolerability of Lumason® i...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippone, A., Kirchin, M. A., Monteith, J., Storto, M. L., Spinazzi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433219/
https://www.ncbi.nlm.nih.gov/pubmed/37600063
http://dx.doi.org/10.3389/fcvm.2023.1225654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433219/
https://www.ncbi.nlm.nih.gov/pubmed/37600063
http://dx.doi.org/10.3389/fcvm.2023.1225654

Ejemplares similares